Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

II-VI Incorporated Chooses Award Winning Veeco IBD System

Published: Saturday, March 22, 2014
Last Updated: Saturday, March 22, 2014
Bookmark and Share
Company has added Veeco’s new Quest™ Optical Monitor for high volume laser optics production.

Veeco Instruments Inc. has announced that II-VI Incorporated, has ordered the SPECTOR-HT™ Ion Beam Deposition (IBD) System and added Veeco’s new Quest™ Optical Monitor, for use in its high-volume production of laser optics.

The R&D-100 award-winning SPECTOR-HT™ IBD System produces the highest quality optical thin films with improved levels of productivity and throughput.

The Quest Optical Monitor provides up to ten times improvement in layer thickness accuracy compared to previous generations for precise manufacturing control.

“Veeco’s SPECTOR-HT IBD System allows us to deliver high quality laser optics faster by achieving superior deposition rates while maintaining exceptional film qualities,” said Mark West, General Manager, II-VI Infrared.

West continued, “The Veeco Quest Optical Monitor upgrade is an incredible breakthrough. It ensures we will have a repeatable, highly productive operation using the latest technology, enabling us to produce the highest quality laser optics.”

Headquartered in Saxonburg, Pennsylvania, II-VI is a global leader in engineered materials and optoelectronic components. Veeco is the market leader in MOCVD, MBE, Ion Beam and other advanced thin film process technologies.

“II-VI is an optical coating leader and their endorsement of the SPECTOR-HT is clear indication of its exceptional value,” said Jim Northup, Vice President and General Manager of Veeco MBE, Optical Systems and Ion Sources. “As the optics industry seeks faster deposition rates and more repeatable processes, Veeco's SPECTOR-HT IBD System, coupled with the new Quest Optical Monitor, achieves unprecedented levels of productivity by offering the highest throughput for optical thin film manufacturers.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Veeco Wins Innovation Award with EPIK700 MOCVD System
CS Industry Innovation Award for the highest distinction in compound semiconductor manufacturing.
Friday, April 03, 2015
Veeco Appoints Shubham Maheshwari as Chief Financial Officer
Mr. Maheshwari replaces David D. Glass.
Friday, May 16, 2014
Veeco Completes Purchase of Synos Technology
Veeco granted equity awards to 52 Synos employees.
Friday, October 04, 2013
Imec and Veeco Announce Collaboration
Both Companies collaborate in GaN-on-Si devices for LED and power electronics applications.
Friday, September 27, 2013
Veeco to Purchase Synos Technology
Fast array scanning ALD technology enables flexible OLED displays.
Friday, September 20, 2013
NANEO Precision IBS Coatings GmbH Expands Manufacturing Capacity
NANEO has recently ordered a SPECTOR® Ion Beam Deposition system.
Monday, July 01, 2013
Hangzhou Silan Azure Expands Manufacturing Capacity with Veeco MOCVD
Veeco's TurboDisc® K465i™ MOCVD systems will be used to expand Silan’s manufacturing capacity for HB LEDs.
Tuesday, October 30, 2012
HC SemiTek Purchases Additional Veeco MOCVD Systems
HC SemiTek has purchased TurboDisc® MaxBright® GaN MOCVD systems for LED production.
Tuesday, October 23, 2012
SemiLEDs Qualifies Veeco MOCVD System
Veeco TurboDisc® K465i™ GaN MOCVD system for high volume LED production.
Thursday, February 09, 2012
Scientific News
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!